|Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients|
Bmj 324 (7329), 71-86, 2002
|Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins|
Lancet 366 (9493), 1267-1278, 2005
|Heart disease and stroke statistics-2017 update: a report from the American Heart Association.|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, J Floyd, ...
circulation 135 (10), e146-e603, 2017
|European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other …|
Authors/Task Force Members:, J Perk, G De Backer, H Gohlke, I Graham, ...
European heart journal 33 (13), 1635-1701, 2012
|Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.|
C Baigent, L Blackwell, J Emberson, LE Holland, C Reith, N Bhala, R Peto, ...
Lancet (London, England) 376 (9753), 1670-1681, 2010
|Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies|
Prospective Studies Collaboration
The Lancet 373 (9669), 1083-1096, 2009
|2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute …|
M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...
European heart journal 37 (3), 267-315, 2016
Lancet 345 (8951), 669-85, 1995
|Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials|
Blood Pressure Lowering Treatment Trialists' Collaboration
The Lancet 362 (9395), 1527-1535, 2003
|Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.|
C Baigent, L Blackwell, R Collins, J Emberson, J Godwin, R Peto, J Buring, ...
Lancet (London, England) 373 (9678), 1849-1860, 2009
|The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo …|
C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ...
The Lancet 377 (9784), 2181-2192, 2011
|Cholesterol Treatment Trialists'(CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 …|
Lancet 366, 1267-1278, 2005
|Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials|
PM Kearney, C Baigent, J Godwin, H Halls, JR Emberson, C Patrono
Bmj 332 (7553), 1302-1308, 2006
|American Heart Association statistics committee and stroke statistics subcommittee|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
|The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.|
B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, EH Barnes, ...
Lancet (London, England) 380 (9841), 581-590, 2012
|Low-dose aspirin for the prevention of atherothrombosis|
C Patrono, LA García Rodríguez, R Landolfi, C Baigent
New England Journal of Medicine 353 (22), 2373-2383, 2005
|Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient …|
J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ...
The Lancet 384 (9958), 1929-1935, 2014
|Revascularization versus medical therapy for renal-artery stenosis|
New England Journal of Medicine 361 (20), 1953-1962, 2009
|The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST …|
IST-3 Collaborative Group
The Lancet 379 (9834), 2352-2363, 2012
|Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial|
CRASH Trial Collaborators
The Lancet 364 (9442), 1321-1328, 2004